Bridging Subjective Symptoms and Objective Imaging in Chronic Rhinosinusitis: Impact of an Adaptive Sino-Nasal Outcome Test

Highlight

• A novel adaptive version of the Sino-Nasal Outcome Test (SNOT) demonstrates a significant association with objective sinus imaging (Lund-Mackay CT scores) in chronic rhinosinusitis (CRS).
• Traditional static SNOT instruments showed minimal correlation with imaging findings, highlighting the improved sensitivity of adaptive testing methods based on item response theory.
• The adaptive SNOT also differentiated CRS from allergic rhinitis symptoms, potentially improving diagnostic accuracy and patient stratification.
• Adaptive nasal domain scores correlated with endoscopic findings and demonstrated clinically meaningful probabilities of sinus disease severity assessed by imaging.

Study Background

Chronic rhinosinusitis (CRS) is a prevalent inflammatory condition of the sinonasal mucosa characterized by persistent symptoms and significant impairment in quality of life. The multifactorial etiology and overlapping features with conditions such as allergic rhinitis complicate accurate diagnosis and tailored management. The widely used Sino-Nasal Outcome Test (SNOT-22), a 22-item patient-reported outcome measure (PROM), has traditionally offered a subjective assessment of symptom burden. However, previous studies have shown discordances between patient-reported symptom severity by standard static SNOT instruments and objective imaging findings quantified via the Lund-Mackay computed tomography (LMCT) scoring system. This lack of concordance limits clinical utility and research translation, underscoring the need for improved assessment tools that integrate subjective symptoms with objective diagnostic measures.

Study Design

This diagnostic study was conducted from May 2020 to March 2025 involving consecutive patients presenting with CRS or sinonasal complaints across tertiary care and community settings in Massachusetts. A total of 3,661 patients (mean age 50 years; 67% female) completed either the standard static SNOT-22 or a newly developed adaptive SNOT instrument based on item response theory (IRT). Imaging via Lund-Mackay CT was performed in 417 cases to objectively quantify sinus opacification. Secondary assessments included endoscopy scores evaluating sinonasal mucosal status and allergy-related diagnostics to assess comorbid allergic rhinitis.

The study compared associations between SNOT scores (both static and adaptive versions) and LMCT scores using ordinal regression models and calculated corresponding clinical probabilities to assess diagnostic concordance. Internal consistency and reliability of the instruments were analyzed to confirm psychometric properties.

Key Findings

Statistical analysis revealed a high internal consistency within the unidimensional nasal domain of SNOT (Cronbach’s alpha 0.915), affirming the reliability of the symptom measurement. Notably, the standard static SNOT-22 and extended static versions (SNOT-25, -26, -29) showed no significant association with LMCT scores, affirming previously reported discordances between subjective reports and imaging.

Conversely, the novel adaptive SNOT instrument, which dynamically selects items based on patient responses and IRT modeling, demonstrated a robust association with LMCT results. The nasal domain adaptive score showed an odds ratio (OR) of 3.75 (95% CI, 1.90-7.40) for association with the degree of sinus opacification. Incorporating additional domains—ear, sleep, psychological, productivity, and allergy—in the adaptive testing model further strengthened correlations with imaging.

Importantly, the adaptive allergy-focused testing showed an inverse association with LMCT scores (OR 0.47; 95% CI, 0.25-0.88), indicating its ability to differentiate CRS from allergic rhinitis symptoms. This differential diagnostic capacity is clinically impactful, given symptom overlap that often complicates management.

Endoscopy scores displayed similar patterns to adaptive SNOT scores regarding correlations with imaging, supporting the validity of the adaptive instrument in reflecting objective mucosal disease severity.

Moreover, adaptive nasal scores demonstrated increasing probabilities of having LMCT scores greater than 5, a clinically meaningful threshold indicating significant sinus disease. This suggests potential for adaptive SNOT instruments to stratify disease severity and guide clinical decision-making.

Expert Commentary

This study addresses a long-standing challenge in CRS management: the disconnect between patient-reported symptom severity and objective diagnostic findings. The implementation of an adaptive SNOT instrument utilizing item response theory represents an innovative step toward harmonizing subjective symptom assessment with quantifiable imaging data.

The ability to tailor item selection to individual symptom profiles enhances measurement precision and reduces respondent burden by potentially shortening questionnaires without sacrificing diagnostic accuracy. Furthermore, the differential ability to distinguish allergic rhinitis from CRS could refine treatment algorithms, optimizing both medical and surgical interventions.

Limitations include the observational nature of the study and the population restricted to Massachusetts sites, which may affect generalizability. The proportion of patients undergoing CT imaging was a subset (417/3661), which may introduce selection bias. Future studies should assess longitudinal responsiveness of the adaptive instrument to therapeutic interventions and evaluate its performance across diverse geographical and clinical settings.

Conclusion

The novel adaptive Sino-Nasal Outcome Test represents a significant advancement in symptom assessment for chronic rhinosinusitis. By establishing a clear association with objective Lund-Mackay CT imaging and enabling differentiation from allergic rhinitis, the instrument holds promise for enhancing diagnostic accuracy, personalizing management, and improving research outcomes. Adoption of adaptive testing strategies may bridge gaps between patient experiences and clinical evaluations, supporting improved care pathways in CRS.

Funding and ClinicalTrials.gov

The original study did not specify funding sources or clinical trial registration details in the provided abstract. Readers are encouraged to refer to the primary publication for full disclosures.

References

1. Zhang SK, Prince AA, Corrales CE, Stanlie A, Alkhatib S, Piccirillo JF, Elkoumi A, Shin JJ. Concordance Between an Adaptive Sino-Nasal Outcome Test and Imaging Results in Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2026 Jul 1;152(7):650-658. doi:10.1001/jamaoto.2026.3335.

2. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002 Jan;126(1):41-7.

3. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993 Dec;31(4):183-4.

4. DeConde AS, Mace JC, Alt JA, Rudmik L, Soler ZM, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017 Apr;127(4):550-555.

5. Soler ZM, Smith TL. Quality of life outcomes after endoscopic sinus surgery. Otolaryngol Clin North Am. 2010 Dec;43(6):605-12.